Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001374170-25-000084
Filing Date
2025-10-24
Accepted
2025-10-24 16:48:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4770
  Complete submission text file 0001374170-25-000084.txt   6517
Mailing Address BANKPLASSEN 2 P.O BOX 1179 SENTRUM OSLO Q8 0107
Business Address BANKPLASSEN 2 P.O BOX 1179 SENTRUM OSLO Q8 0107 47-24073120
NORGES BANK (Filed by) CIK: 0001374170 (see all company filings)

EIN.: 000000000 | State of Incorp.: Q8 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451 781-208-2466
Upstream Bio, Inc. (Subject) CIK: 0002022626 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94651 | Film No.: 251416697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)